Management of the Pressure Injury Patient with Osteomyelitis: An Algorithm by Nicksic, Peter J. et al.
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
1
Management of the Pressure Injury Patient with Osteomyelitis: An Algorithm 
Peter J Nicksic, BA1, Sarah E Sasor, MD1, Sunil STholpady, MD, PhD, FACS1, William 
A Wooden, MD, FACS1, Luke G Gutwein, MD2
1Division of Plastic & Reconstructive Surgery, Department of Surgery, Indiana 
University, School of Medicine, Indianapolis, IN
2Department of Anatomical Sciences, St. George’s University School of Medicine, 
Grenada, West Indies 
Disclosure Information: Nothing to disclose. 
Correspondence address: 
Peter J. Nicksic 
Indiana University School of Medicine, Division of Plastic Surgery 
535 Barnhill Drive, EH 232 
Indianapolis, IN 46202 
pnicksic@iupui.edu 
(219) 263-8949 
Running Head: Pressure Injury with Osteomyelitis 
Keywords: pressure injury, pressure sore, decubitus ulcer, osteomyelitis, bone infection 
___________________________________________________________________
This is the author's manuscript of the article published in final edited form as:
Nicksic, P. J., Sasor, S. E., Tholpady, S. S., Wooden, W. A., & Gutwein, L. G. (2017). Management of the Pressure Injury 
Patient with Osteomyelitis: An Algorithm. Journal of the American College of Surgeons. 
https://doi.org/10.1016/j.jamcollsurg.2017.08.017
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 2
Introduction 
Pressure injury (PI) is a common complication of inpatient care, affecting an estimated 3 
million patients annually in the United States (1). Risk factors include immobility, 
compromised sensation, malnutrition, urinary or fecal incontinence, and chronic medical 
illness (2). Compliance with established guidelines (pressure offloading, skin care, and 
frequent inspection) is imperative for the prevention of hospital-acquired pressure injury. 
Unavoidable PI does, at times, occur and is often related to advanced medical illness (3). 
Patients with physiologic, behavioral, or treatment-related risk factors may develop PI 
complicated by osteomyelitis (OM) despite the adherence to current standards of 
prevention (4). 
 
The National Pressure Ulcer Advisory Panel’s (NPUAP) defines pressure injury as 
localized damage to the skin and underlying soft tissue usually over a bony prominence 
or related to a medical device (Table 1) (5). The sacrum, trochanter, ischium, and heel 
are commonly affected (6). When bacteria within the wound adhere to bone, OM can 
develop. Propagation of bacteria and the formation of biofilms deep within bony 
structures cause an inflammatory response which leads to bone resorption - both by 
decreasing osteoblast function and increasing osteoclast activity (7). This process results 
in a necrotic hollowing of the bone called a sequestrum and is the distinguishing feature 
of chronic OM (8). Chronic OM is unresponsive to systemic antibiotics; surgical 
debridement is required for curative treatment (9). Nearly every case of OM secondary to 
a high grade PI is chronic (10). 
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Despite advancements in both surgical and medical therapies, the long-term recurrence of 
chronic OM remains 20-30 percent (11). Patients with personal, social, and economic risk 
factors for PI are at high risk for recurrence despite initial success at wound coverage. 
The goal of this paper is to review indications for surgical treatment of PI with associated 
OM and to introduce an algorithm for successful treatment. 
 
Pressure Injury-Osteomyelitis Algorithm 
We propose an accurate and simple algorithm for the diagnosis and treatment of OM 
secondary to PI for clinicians and surgeons to follow in patients with high-grade PI and 
suspected OM (Figure 1). The algorithm delineates the steps necessary for an accurate 
diagnosis of OM secondary to a PI. The algorithm then walks through the treatment plan 
for patients with both curative and palliative treatment goals. 
 
Diagnosis 
Osteomyelitis secondary to PI should be suspected in a patient who presents with wounds 
with significant tissue necrosis or exposed bone. While non-specific, laboratory tests can 
be useful to rule out OM. C-reactive protein (CRP) and erythrocyte sedimentation rate 
(ESR) are nearly 100 percent sensitive (12). Unfortunately, absolute values do not 
correlate with short-term outcomes (13). 
 
Imaging is important to support the diagnosis of OM and to localize and grade the 
severity of infection. Plain radiography is the first step - it is useful for detecting bony 
destruction and periosteal reaction (14). An involucrum, a thick sheath of new periosteal 
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bone surrounding a sequestrum, is sometimes visible (15). If OM is suspected on plain 
films, it is appropriate to proceed directly to bone biopsy and culture. 
 
Plain XR has a high false negative rate in OM; it is positive only when half of the 
affected bone has necrosed which is typically occurs at least one month into disease 
progression (14). For this reason, more sensitive imaging techniques should follow a 
negative radiograph. Magnetic resonance imaging (MRI) is the imaging modality of 
choice for OM for its superior specificity and comparable sensitivity (16). In patients who 
are not candidates for MRI, three-phase technetium-99 bone scintigraphy and leukocyte 
scintigraphy are useful adjuncts (14). 
 
While laboratory tests and imaging are useful in the work-up of OM, a bone biopsy and 
culture is needed to confirm the diagnosis (15). Three separate cultures and one 
histopathological analysis should be done per ulcer (17). Specimens should be obtained 
after debridement of overlying tissue to decrease the risk of contamination (9); cultures 
from superficial wounds or sinus tracts are not useful (18, 19). Wound cultures are 
considered positive if at least one of three shows a non-commensal organism 
concentration of >100,000 per gram tissue or all three biopsies are positive for 
commensal organisms (20). Histopathology typically shows a lymphoplasmacytic 
infiltrate and bone necrosis (9). 
 
Medical Optimization 
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Many pressure injuries have the ability to heal without surgery once risk factors are 
corrected. When OM is present, infected or necrotic bone should be debrided, if possible 
(21). Patients should then be medically optimized before considering reconstructive 
surgery. 
 
Patient repositioning, specialized mattresses, and foam coverings are the mainstay of 
pressure off-loading and are an integral in decreasing the size and severity of PI prior to 
intervention (22, 23). As many PI are malnourished or nutritionally deficient, it is also 
necessary for the patient to have adequate micronutrients, protein, and caloric intake to 
heal surgical wounds (24). Medical comorbidities should also be controlled prior to 
surgical intervention, as they may adversely affect wound healing. Lastly, social barriers 
affecting the patient’s ability to care for their wounds should be assessed and corrected. 
 
Treatment 
Ideal candidates for reconstructive surgery do not use nicotine, have good social support, 
are nutritionally optimized, and have good surgical options for coverage. Patients who do 
not meet these standards are likely to benefit from a palliative approach to treatment with 
the goal of arresting progression of infection and reducing bioburden without 
reconstructive surgery. 
 
Surgical principles for the treatment of pressure sores include complete excision of the 
wound (soft tissue, bursae, and affected bone), elimination of dead space, and wound 
resurfacing. Flaps should be large enough to provide adequate cushioning over any 
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remaining bony prominences. Suture lines should be placed away from areas with direct 
pressure. Flap design should allow for re-advancement, if possible, and should not violate 
adjacent flap territories. 
 
Debridement 
Surgical debridement is recommended for all patients with pressure injury and 
osteomyelitis who are deemed operative candidates (21). Aggressive, serial debridement 
back to healthy-appearing, vascularized tissue is required. The purpose of debridement is 
to convert a chronic wound into an acute wound; removing affected tissue and its 
inflammatory cytokines allows the remaining wound to heal as if it was acutely injured. 
Necrotic bone may harbor biofilms and should also be aggressively debrided (Figure 
2)(10). Biofilms must be mechanically disrupted by either high-pressure washes or 
excision or else infection is likely to recur (25). The goal of debridement is a clean 
wound bed that has tissue of white, yellow, or red appearance (Figure 3). 
 
Definitive Treatment 
Antibiotic Therapy 
For patients who are candidates for definitive wound closure, targeted parenteral 
antibiotic treatment should be initiated after debridement and continued for 4-6 weeks 
(10). Some sources recommend and additional 2-4 weeks of oral antibiotics beyond this 
(18). Choice of antibiotic agent should be guided by culture, susceptibility, and drug 
penetration into bone (19, 26, 27). 
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It is important to realize that antibiotic therapy alone cannot cure chronic OM, and a 
person with chronic OM should not be on systemic antibiotics indefinitely (28). The goal 
of targeted antibiotic therapy is to bridge the gap between debridement and wound 
closure. 
 
Reconstruction 
After debridement, the patient should have their wound dressed until reconstruction is 
possible. Negative pressure wound therapy (NPWT) is popular in this setting (10). After 
the local wound control and initiation of antibiotic therapy, CRP levels should trend 
down (13). When granulation tissue is present, it is safe to plan for permanent wound 
coverage (10). Soft tissue defect should be reconstructed with the least invasive 
procedure that will offer the most benefit to the patient. Myocutaneous and 
fasciocutaneous flaps offer similar resilience to compression (29). Common local flap 
options are V-Y advancement flaps, gluteal rotation or advancement flaps, hamstring 
flaps, and pedicled tensor fascia lata flaps (30). Free flaps are rarely indicated in this 
patient population. 
 
Palliative treatment 
Some patients are not candidates for definitive wound coverage for various medical and 
non-medical reasons. In these instances, it is best to pursue palliative treatment with the 
goals of arresting disease progression, decreasing bacterial bioburden, and reducing 
wound size. If the patient is an operative candidate, it is best to adequately debride 
infectious or necrotic material as described above. Bacteria in high concentrations alter 
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the microenvironment and cellular metabolism within the wound, favoring progression of 
chronic wounds (31). With adequate debridement there is still potential to restore a 
balance in the cellular microenvironment (Figure 2) (32). If a patient’s condition does 
not allow for complete debridement, additional solutions include partial debridement, 
bone trephination, and drainage tube placement (10). 
 
Systemic antibiotic therapy is inappropriate in a palliative care patient if the patient is 
stabilized after debridement (33). Antibiotics will not penetrate the largely avascular bone 
abscess or biofilms if they have not been completely cleared from the wound; they also 
carry the risk of an opportunistic infection. 
 
An important aspect of palliative management is wound care. It is critical to keep the 
wound clean. This can be difficult, especially in patients that are incontinent. Temporary 
or permanent urinary and/or fecal diversion may benefit some patients. There are 
innumerable wound care products available for the treatment of pressure injury. A meta-
analysis of various dressings and topical agents found no significant difference in 
outcomes (34). Options include mechanical debridement with wet-to-dry dressings or 
Dakin’s-soaked gauze, enzymatic debridement with collagenase or Manuka honey, and 
various antibiotic impregnated foams and sponges, among others. NPWT is of special 
utility in this population as it aids in both wound contraction and optimization of the 
microenvironment of the wound for epithelialization while shielding the wound from 
further inoculation (35). NPWT should not be applied to wounds with grossly infected or 
necrotic tissue present (35). 
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If palliative care is the known to be the goal at the onset of PI diagnosis, imaging studies, 
bone biopsies, and cultures should not be performed since they will not guide treatment. 
 
Conclusion 
Pressure injury complicated by chronic osteomyelitis is a common problem in 
hospitalized patients. An algorithmic approach to diagnosis and treatment is useful to 
help determine if a patient may benefit from definitive wound coverage. Many patients 
may be better served by a palliative approach to care. With a 49 percent 12-month 
recurrence rate, curative measures for PI should only be pursued in a medically and 
nutritionally optimized patient with a robust social support system (36). 
 
Our algorithmic approach to pressure ulcer injuries has aided understanding and 
communication of the complex care in this patient population across disciplines in 
medicine. For successful wound closure, multiple clinical variables must be addressed 
such as debridement, incontinence, antibiotic therapy, nutritional state, optimal wound 
care, off-loading, and the social support of the patient. With a plan to address each of 
these variables, care of the pressure injury patient is optimized. 
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Table 1. Pressure Injury Staging 
Stage Description 
I Intact skin with nonblanchable erythema. Pigmented skin may not differ 
from surrounding skin. 
II Loss of epidermis, partial thickness loss of dermis. Open or closed blister. 
III Full-thickness loss of skin. Exposure of subcutaneous tissue. No 
exposure of muscle, tendon, or bone. 
IV Full-thickness loss of skin. Exposure of muscle, tendon, or bone. 
US Unstageable injury. Eschar exposed with unknown depth of necrotic 
tissue. 
NPUAP staging guidelines for pressure injury.(5) 
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Figure Legends 
Figure 1. Diagnosis and treatment algorithm for the pressure injury patient with 
suspected osteomyelitis. The algorithm includes both curative and palliative treatment 
goals. NPWT, negative pressure wound therapy; CRP, C-reactive protein; ESR, 
erythrocyte sedimentation rate; SCI, spinal cord injury. 
 
Figure 2. The role of debridement in converting cellular microenvironment of chronic 
wounds to healing wounds. There is an imbalanced cellular microenvironment between 
healing wounds and chronic wounds. This imbalance can be rectified through adequate 
debridement of devitalized tissue, which perpetuates the chronic immunological response 
inhibiting normal wound healing. ROS, reactive oxygen species; RNS, reactive nitrogen 
species. 
 
Figure 3. (A) An unstageable trochanteric pressure ulcer harbors chronic inflammatory 
tissue that inhibits the normal phases of wound healing. (B) The sinus tract is stained with 
methylene blue to visually guide complete excisional debridement of the chronic 
inflammatory tissue and wound bursa. After excision and pulse irrigation washout, tissue 
is sent for culture and if osteomyelitis is suspected bone biopsy and cultures are obtained. 
(C) The wound is packed for 12 hours with moistened gauze to ensure hemostasis. 
Transition to negative pressure wound therapy is performed on postoperative day 1. 
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